Wealthspire Advisors (New York)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,600
Closed -$262K 1067
2025
Q4
$262K Buy
1,600
+1,474
+1,170% +$231K ﹤0.01% 862
2025
Q3
$16.8K Buy
+126
New +$15.3K ﹤0.01% 1760

Other funds holding RGEN

Wealthspire Advisors (New York)'s RGEN Position: Q1 2026 in Review

Wealthspire Advisors (New York) sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,600 shares — an estimated $262K sold.

Wealthspire Advisors (New York) first reported a position in RGEN in Q3 2025 and held it in 2 quarters. The position peaked at $262K in Q4 2025. 443 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Wealthspire Advisors (New York) reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1,600 Repligen shares in Q1 2026, an estimated $262K.
  • Wealthspire Advisors (New York) first reported a position in Repligen in Q3 2025 and held it in 2 quarters.
  • Wealthspire Advisors (New York)'s Repligen position peaked at $262K in Q4 2025.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.